Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brockmeier

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Pharmacology and Therapeutics|December 1, 1995
Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurementsD Brockmeier
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1986
Model-free evaluation and mean-time concept in pharmacokineticsD Brockmeier
Arzneimittel-Forschung|January 1, 1981
[Reconstruction of dissolution profiles of microcapsulated formulations by the mean and variance of dissolution times (author's transl)]D Brockmeier
Biopharmaceutics & Drug Disposition|April 1, 1985
Presystemic elimination and mean residence timeD Brockmeier
European Journal of Clinical Pharmacology|January 1, 1988
Estimating reduced availability due to first pass elimination from relative total clearance and renal clearanceD Brockmeier
International Journal of Clinical Pharmacology and Therapeutics|December 10, 1999
Mean time concept and component analysis in pharmacokineticsD Brockmeier
Arzneimittel-Forschung|January 1, 1984
In vitro-in vivo correlation, a time scaling problem? Evaluation of mean timesD Brockmeier
Methods and Findings in Experimental and Clinical Pharmacology|October 28, 1998
Tight binding influencing the future of pharmacokineticsD Brockmeier
European Journal of Clinical Pharmacology|January 1, 1985
Mean time and first-pass metabolismD Brockmeier, J Ostrowski
Journal of Clinical Gastroenterology|January 1, 1989
Pharmacokinetic characteristics of roxatidineW Bender, D Brockmeier
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Pharmacology and Therapeutics|December 1, 1995
Tight binding of ramiprilat to ACE: consequences for pharmacokinetic and pharmacodynamic measurementsD Brockmeier
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1986
Model-free evaluation and mean-time concept in pharmacokineticsD Brockmeier
Arzneimittel-Forschung|January 1, 1981
[Reconstruction of dissolution profiles of microcapsulated formulations by the mean and variance of dissolution times (author's transl)]D Brockmeier
Biopharmaceutics & Drug Disposition|April 1, 1985
Presystemic elimination and mean residence timeD Brockmeier
European Journal of Clinical Pharmacology|January 1, 1988
Estimating reduced availability due to first pass elimination from relative total clearance and renal clearanceD Brockmeier
International Journal of Clinical Pharmacology and Therapeutics|December 10, 1999
Mean time concept and component analysis in pharmacokineticsD Brockmeier
Arzneimittel-Forschung|January 1, 1984
In vitro-in vivo correlation, a time scaling problem? Evaluation of mean timesD Brockmeier
Methods and Findings in Experimental and Clinical Pharmacology|October 28, 1998
Tight binding influencing the future of pharmacokineticsD Brockmeier
European Journal of Clinical Pharmacology|January 1, 1985
Mean time and first-pass metabolismD Brockmeier, J Ostrowski
Journal of Clinical Gastroenterology|January 1, 1989
Pharmacokinetic characteristics of roxatidineW Bender, D Brockmeier
Pageof 5